61 related articles for article (PubMed ID: 17135006)
1. O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) uptake in mouse thymoma cells, and its biodistribution in mice and human volunteers.
Abe K; Hayashi K; Sasaki M; Koga H; Kaneko K; Sawamoto H; Himuro K; Honda H
Acta Radiol; 2006 Dec; 47(10):1042-8. PubMed ID: 17135006
[TBL] [Abstract][Full Text] [Related]
2. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
Heiss P; Mayer S; Herz M; Wester HJ; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 1999 Aug; 40(8):1367-73. PubMed ID: 10450690
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.
Wester HJ; Herz M; Weber W; Heiss P; Senekowitsch-Schmidtke R; Schwaiger M; Stöcklin G
J Nucl Med; 1999 Jan; 40(1):205-12. PubMed ID: 9935078
[TBL] [Abstract][Full Text] [Related]
4. Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain.
Makrides V; Bauer R; Weber W; Wester HJ; Fischer S; Hinz R; Huggel K; Opfermann T; Herzau M; Ganapathy V; Verrey F; Brust P
Brain Res; 2007 May; 1147():25-33. PubMed ID: 17343835
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
6. O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
Langen KJ; Hamacher K; Weckesser M; Floeth F; Stoffels G; Bauer D; Coenen HH; Pauleit D
Nucl Med Biol; 2006 Apr; 33(3):287-94. PubMed ID: 16631076
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of D-isomers of O-18F-fluoromethyl, O-18F-fluoroethyl and O-18F-fluoropropyl tyrosine as tumour imaging agents in mice.
Tsukada H; Sato K; Fukumoto D; Kakiuchi T
Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1017-24. PubMed ID: 16699766
[TBL] [Abstract][Full Text] [Related]
8. PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.
Pauleit D; Stoffels G; Schaden W; Hamacher K; Bauer D; Tellmann L; Herzog H; Bröer S; Coenen HH; Langen KJ
J Nucl Med; 2005 Mar; 46(3):411-6. PubMed ID: 15750152
[TBL] [Abstract][Full Text] [Related]
9. Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.
Salber D; Stoffels G; Pauleit D; Oros-Peusquens AM; Shah NJ; Klauth P; Hamacher K; Coenen HH; Langen KJ
J Nucl Med; 2007 Dec; 48(12):2056-62. PubMed ID: 18006612
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in mice.
Chang CH; Wang HE; Wu SY; Fan KH; Tsai TH; Lee TW; Chang SR; Liu RS; Chen CF; Chen CH; Fu YK
Anticancer Res; 2006; 26(2A):917-25. PubMed ID: 16619487
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis and preliminary studies of O-(2-[18F] fluoroethyl)-L-tyrosine as a positron emission tomography imaging agent].
Dang YH; Wang SZ; Cheng X; Zhou Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):370-2. PubMed ID: 12905655
[TBL] [Abstract][Full Text] [Related]
12. O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.
Weckesser M; Langen KJ; Rickert CH; Kloska S; Straeter R; Hamacher K; Kurlemann G; Wassmann H; Coenen HH; Schober O
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):422-9. PubMed ID: 15650870
[TBL] [Abstract][Full Text] [Related]
13. Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence.
Spaeth N; Wyss MT; Weber B; Scheidegger S; Lutz A; Verwey J; Radovanovic I; Pahnke J; Wild D; Westera G; Weishaupt D; Hermann DM; Kaser-Hotz B; Aguzzi A; Buck A
J Nucl Med; 2004 Nov; 45(11):1931-8. PubMed ID: 15534065
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of O-(3-[18F]fluoropropyl)-L-tyrosine as an oncologic PET tracer.
Tang G; Wang M; Tang X; Luo L; Gan M
Nucl Med Biol; 2003 Oct; 30(7):733-9. PubMed ID: 14499331
[TBL] [Abstract][Full Text] [Related]
15. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
Pöpperl G; Kreth FW; Herms J; Koch W; Mehrkens JH; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
J Nucl Med; 2006 Mar; 47(3):393-403. PubMed ID: 16513607
[TBL] [Abstract][Full Text] [Related]
16. O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study.
Weber WA; Wester HJ; Grosu AL; Herz M; Dzewas B; Feldmann HJ; Molls M; Stöcklin G; Schwaiger M
Eur J Nucl Med; 2000 May; 27(5):542-9. PubMed ID: 10853810
[TBL] [Abstract][Full Text] [Related]
17. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.
Pauleit D; Floeth F; Tellmann L; Hamacher K; Hautzel H; Müller HW; Coenen HH; Langen KJ
J Nucl Med; 2004 Mar; 45(3):374-81. PubMed ID: 15001676
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro evaluation of 18F labeled tyrosine derivatives as potential positron emission tomography (PET) imaging agents.
Wang L; Qu W; Lieberman B; Ploessl K; Kung HF
Bioorg Med Chem Lett; 2010 Jun; 20(12):3482-5. PubMed ID: 20529679
[TBL] [Abstract][Full Text] [Related]
19. Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine.
Pauleit D; Floeth F; Herzog H; Hamacher K; Tellmann L; Müller HW; Coenen HH; Langen KJ
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):519-24. PubMed ID: 12589478
[TBL] [Abstract][Full Text] [Related]
20. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
Pauleit D; Zimmermann A; Stoffels G; Bauer D; Risse J; Flüss MO; Hamacher K; Coenen HH; Langen KJ
J Nucl Med; 2006 Feb; 47(2):256-61. PubMed ID: 16455631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]